GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EPS Holdings Inc (TSE:4282) » Definitions » Debt-to-Equity

EPS Holdings (TSE:4282) Debt-to-Equity : 0.24 (As of Jun. 2021)


View and export this data going back to 2004. Start your Free Trial

What is EPS Holdings Debt-to-Equity?

EPS Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was 円10,753 Mil. EPS Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was 円150 Mil. EPS Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2021 was 円45,981 Mil. EPS Holdings's debt to equity for the quarter that ended in Jun. 2021 was 0.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for EPS Holdings's Debt-to-Equity or its related term are showing as below:

TSE:4282's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

EPS Holdings Debt-to-Equity Historical Data

The historical data trend for EPS Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EPS Holdings Debt-to-Equity Chart

EPS Holdings Annual Data
Trend Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.06 0.04 0.05 0.09

EPS Holdings Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.09 0.09 0.08 0.24

Competitive Comparison of EPS Holdings's Debt-to-Equity

For the Diagnostics & Research subindustry, EPS Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EPS Holdings's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, EPS Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where EPS Holdings's Debt-to-Equity falls into.



EPS Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

EPS Holdings's Debt to Equity Ratio for the fiscal year that ended in Sep. 2020 is calculated as

EPS Holdings's Debt to Equity Ratio for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EPS Holdings  (TSE:4282) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


EPS Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of EPS Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


EPS Holdings (TSE:4282) Business Description

Traded in Other Exchanges
N/A
Address
Tsuruya Building, 2-23 Shimomiyabicho, Shiniuku-ku, Tokyo, JPN, 162-0822
EPS Holdings Inc is in the business of clinical trials required for drug and medical device development. Its services include clinical trial planning, protocol development, patient registration, drug randomization, project management, data management, statistical analysis, medical device development, pharmacovigilance, audit, international development, data center operation, analysis, and medical convention. The company focuses on Cardiovascular, Central nervous system, Gastroenterology therapeutic areas.

EPS Holdings (TSE:4282) Headlines

No Headlines